ML15272A395

From kanterella
Revision as of 07:13, 31 October 2019 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
Jump to navigation Jump to search
Updated Construction Completion Dates for Shine Medical Technologies, Inc
ML15272A395
Person / Time
Site: SHINE Medical Technologies
Issue date: 09/29/2015
From: Piefer G
SHINE Medical Technologies
To:
Document Control Desk, Office of Nuclear Reactor Regulation
References
SMT-2015-055
Download: ML15272A395 (2)


Text

September 29, 2015 SMT-2015-055 10 CFR 50.33 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555

References:

(1) SHINE Medical Technologies, Inc. letter to NRC, dated March 26, 2013, Part One of the SHINE Medical Technologies, Inc. Application for Construction Permit (ML130880226)

(2) SHINE Medical Technologies, Inc. letter to NRC, dated May 31, 2013, Part Two of the SHINE Medical Technologies, Inc. Application for Construction Permit (ML13172A361)

(3) SHINE Medical Technologies, Inc. letter to NRC, dated May 15, 2014, Updated General Information for SHINE Medical Technologies, Inc.

(ML14135A360)

(4) SHINE Medical Technologies, Inc. letter to NRC, dated September 16, 2015, Updated General Information for SHINE Medical Technologies, Inc.

(ML15259A272)

Updated Construction Completion Dates for SHINE Medical Technologies, Inc.

Pursuant to 1O CFR 50.30, SHINE Medical Technologies, Inc. (SHINE) submitted an application for a construction permit to construct a medical isotope facility to be located in Janesville, WI (References 1 and 2). Enclosure 4 of Reference (1) provided the public version of general information in accordance with 1O CFR 50.33, which included construction completion dates.

SHINE previously provided updated general information via Reference (3) and Reference (4). provides updated general information reflecting revised construction completion dates.

If you have any questions, please contact Mr. Jim Costedio, Licensing Manager, at 608/210-1730.

I declare under the penalty of perjury that the foregoing is true and correct.

Executed on September 29, 2015.

Very truly yours, V~/J~

Gregory Piefer, Ph.D.

Chief Executive Officer SHINE Medical Technologies, Inc.

Docket No. 50-608 Enclosure cc: Administrator, Region Ill, USNRC Project Manager, USNRC Environmental Project Manager, USNRC Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health 2555 Industrial Drive I Monona, WI 53713 IP (608) 210-1060 IF (608) 210-2504 I www.shinemed.com

ENCLOSURE 1 SHINE MEDICAL TECHNOLOGIES, INC.

UPDATED CONSTRUCTION COMPLETION DATES FOR SHINE MEDICAL TECHNOLOGIES, INC.

Construction Completion SHINE currently expects to complete construction of the facility by December 31, 2017 at the earliest, and December 31, 2022 at the latest.

Page 1 of 1